| Filed On | Filing |
|---|---|
| 22 Oct 2026 |
Form 3/A: Maraldo David R., EVP & Pres. MMD
Holds 2,870.7727 shares of Common Stock - 401(k) Plan |
| 15 Oct 2026 | 25-NSE |
| 13 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
____________________________________________________________________________ |
| 01 Oct 2026 |
Form 4: Seidman Christine E, Director
Granted 55.9149 Phantom Stock ($8.12K) |
| 01 Oct 2026 |
Form 4: Karsanbhai Surendralal Lanca, Director
Granted 111.8299 Phantom Stock ($16.3K) |
| 01 Oct 2026 |
Form 4: Coe Mary Ellen, Director
Granted 206.4552 Phantom Stock ($30K) |
| 01 Sep 2026 |
Form 3: Gupta Gaurav K, EVP, CIDO
Holds 750 shares of Common Stock |
| 13 Aug 2026 |
Form 4: Guindo Chirfi, EVP, Access, Policy & Comms
Sold 10,000 shares ($1.35M) |
| 13 Aug 2026 | 144 |
| 13 Aug 2026 |
Form 4: Zachary Jennifer, EVP, General Counsel
Received 54,927 shares by exercise or conversion ($6.03M) · Sold 80,315 shares ($10.7M) |
| 12 Aug 2026 | 144 |
| 12 Aug 2026 | 144 |
| 12 Aug 2026 |
Form 4: DeLuca Richard R., EVP&Pres, Merck Animal Heallth
Sold 20,784 shares ($2.71M) · Sold 12,837 shares ($1.69M) · Sold 11,699 shares ($1.54M) |
| 11 Aug 2026 | 144 |
| 10 Aug 2026 | 144 |
| 10 Aug 2026 |
Form 4: DeLuca Richard R., EVP&Pres, Merck Animal Heallth
Sold 6,050 shares ($789K) |
| 07 Aug 2026 |
Form 4: Maraldo David R., EVP & Pres. MMD
Received 18,706 shares by exercise or conversion ($1.54M) · Sold 18,706 shares ($2.41M) |
| 07 Aug 2026 |
Form 4: Williams David Michael, EVP,Chief Info&Digital Officer
Received 52,847 shares by exercise or conversion ($3.94M) · Sold 52,847 shares ($6.81M) |
| 07 Aug 2026 |
Form 4: Guindo Chirfi, EVP, Access, Policy & Comms
Sold 15,000 shares ($1.97M) |
| 07 Aug 2026 | 13F-HR |
Loading...
